President Donald Trump on coronavirus vaccine development and distribution
Coronavirus vaccine not ready for US presidential election
Pfizer, following others, has pushed back its release dates
WASHINGTON – President Donald Trump’s prediction that the coronavirus vaccine will be ready before the presidential elections on November 3 is not destined to come true.
Pharmaceutical giant Pfizer announced it will not seek emergency approval for its coronavirus vaccine until the end of November.
Two other leaders in vaccine development have suspended work. The fourth is unlikely to receive results before the end of the year.
Trump has repeatedly said that the vaccine will be available to many even before the election as part of the administration’s highly publicized Operation Warp Speed, aimed at accelerating its development..
Leading government and nongovernmental scholars have long argued that the announced deadlines are unrealistic..
Download Adobe Flash Player
Coronavirus vaccine: 10 drugs in final phase, none approved
The code has been copied to your clipboard.
Share on Facebook
Share on Twitter
The URL has been copied to your clipboard
No media source currently available
240p | 9.4MB
360p | 14.1MB
480p | 23.2MB
720p | 52.9MB
1080p | 72.4MB
In a statement, Pfizer CEO Albert Burla said the company might find out by the end of October if its vaccine is working. However, she will be able to judge with confidence about her safety not earlier than the end of November..
“Safety is and will be our top priority,” Burla wrote..
Russian service &# 171; Voices of America&# 187;
I will follow